Key facts
- It has raised $127.7M; the latest was Debt - General ($32.6M) in Oct 2024.
- Notable investors include Oaktree Capital Management, K2 HealthVentures, Madryn Asset Management.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Dialyze Direct
- ·The full record, as it builds
Funding rounds
No funding rounds for Dialyze Direct are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dialyze Direct
Provider of staff-assisted home hemodialysis services intended to provide care to elderly patients. The company aims to offer customized and coordinated dialysis care through its registered nurses, dieticians, and social workers, providing geriatric patients with reduced overall costs by improving outcomes, eliminating transportation, and minimizing re-hospitalizations.
- Sector
- Healthcare
- HQ
- Neptune, NJ, United States
- Founded
- 2015
- Employees
- 350
- Website
- dialyzedirect.com/
- Ownership
- Privately Held (backing)
Dialyze Direct doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dialyze Direct shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dialyze Direct in its N-PORT filings yet. We sweep new filings monthly.